nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—melanoma	0.473	1	CbGaD
Etravirine—CYP3A4—Temozolomide—melanoma	0.117	0.376	CbGbCtD
Etravirine—ABCB1—Dactinomycin—melanoma	0.0712	0.229	CbGbCtD
Etravirine—CYP3A4—Vemurafenib—melanoma	0.0642	0.206	CbGbCtD
Etravirine—ABCB1—Docetaxel—melanoma	0.0368	0.118	CbGbCtD
Etravirine—CYP3A4—Docetaxel—melanoma	0.022	0.0708	CbGbCtD
Etravirine—Neuropathy peripheral—Vemurafenib—melanoma	0.0017	0.00905	CcSEcCtD
Etravirine—Haemoglobin decreased—Docetaxel—melanoma	0.00153	0.00815	CcSEcCtD
Etravirine—Connective tissue disorder—Vemurafenib—melanoma	0.00153	0.00814	CcSEcCtD
Etravirine—Disorientation—Bleomycin—melanoma	0.00153	0.00811	CcSEcCtD
Etravirine—Erythema multiforme—Vemurafenib—melanoma	0.00148	0.00784	CcSEcCtD
Etravirine—Gynaecomastia—Carmustine—melanoma	0.00147	0.00781	CcSEcCtD
Etravirine—Eye disorder—Vemurafenib—melanoma	0.00146	0.00774	CcSEcCtD
Etravirine—Cardiac disorder—Vemurafenib—melanoma	0.00145	0.00769	CcSEcCtD
Etravirine—Hepatic failure—Dactinomycin—melanoma	0.00142	0.00753	CcSEcCtD
Etravirine—Angiopathy—Vemurafenib—melanoma	0.00142	0.00752	CcSEcCtD
Etravirine—Mediastinal disorder—Vemurafenib—melanoma	0.00141	0.00747	CcSEcCtD
Etravirine—Diabetes mellitus—Carmustine—melanoma	0.00137	0.00728	CcSEcCtD
Etravirine—Malnutrition—Vemurafenib—melanoma	0.00136	0.00721	CcSEcCtD
Etravirine—Hepatic failure—Temozolomide—melanoma	0.00128	0.00681	CcSEcCtD
Etravirine—Amnesia—Carmustine—melanoma	0.00127	0.00674	CcSEcCtD
Etravirine—Amnesia—Temozolomide—melanoma	0.00123	0.00652	CcSEcCtD
Etravirine—Bronchospasm—Bleomycin—melanoma	0.00116	0.00617	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00115	0.0061	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00115	0.0061	CcSEcCtD
Etravirine—Infection—Vemurafenib—melanoma	0.0011	0.00585	CcSEcCtD
Etravirine—Inflammation—Docetaxel—melanoma	0.00109	0.00578	CcSEcCtD
Etravirine—Nervous system disorder—Vemurafenib—melanoma	0.00109	0.00577	CcSEcCtD
Etravirine—Skin disorder—Vemurafenib—melanoma	0.00108	0.00572	CcSEcCtD
Etravirine—Dry skin—Temozolomide—melanoma	0.00106	0.00561	CcSEcCtD
Etravirine—Rilpivirine—ABCB1—melanoma	0.00104	1	CrCbGaD
Etravirine—Breast disorder—Temozolomide—melanoma	0.00104	0.00553	CcSEcCtD
Etravirine—Acute coronary syndrome—Bleomycin—melanoma	0.00104	0.00551	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00104	0.00551	CcSEcCtD
Etravirine—Myocardial infarction—Bleomycin—melanoma	0.00103	0.00548	CcSEcCtD
Etravirine—Stomatitis—Bleomycin—melanoma	0.00103	0.00545	CcSEcCtD
Etravirine—Abdominal distension—Temozolomide—melanoma	0.001	0.00533	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000974	0.00517	CcSEcCtD
Etravirine—Decreased appetite—Vemurafenib—melanoma	0.000964	0.00512	CcSEcCtD
Etravirine—Stomatitis—Dactinomycin—melanoma	0.000958	0.00508	CcSEcCtD
Etravirine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000957	0.00508	CcSEcCtD
Etravirine—Fatigue—Vemurafenib—melanoma	0.000956	0.00508	CcSEcCtD
Etravirine—Constipation—Vemurafenib—melanoma	0.000948	0.00503	CcSEcCtD
Etravirine—Hypoaesthesia—Bleomycin—melanoma	0.000941	0.005	CcSEcCtD
Etravirine—Hyperglycaemia—Carmustine—melanoma	0.00093	0.00494	CcSEcCtD
Etravirine—Renal failure—Carmustine—melanoma	0.000904	0.0048	CcSEcCtD
Etravirine—Neuropathy peripheral—Carmustine—melanoma	0.000901	0.00479	CcSEcCtD
Etravirine—Hyperglycaemia—Temozolomide—melanoma	0.000899	0.00477	CcSEcCtD
Etravirine—Stomatitis—Carmustine—melanoma	0.000896	0.00476	CcSEcCtD
Etravirine—Hepatitis—Dactinomycin—melanoma	0.000882	0.00468	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000881	0.00468	CcSEcCtD
Etravirine—Body temperature increased—Vemurafenib—melanoma	0.000877	0.00465	CcSEcCtD
Etravirine—Neuropathy peripheral—Temozolomide—melanoma	0.000871	0.00462	CcSEcCtD
Etravirine—Stomatitis—Temozolomide—melanoma	0.000866	0.0046	CcSEcCtD
Etravirine—Hepatic failure—Docetaxel—melanoma	0.000853	0.00453	CcSEcCtD
Etravirine—Hepatobiliary disease—Temozolomide—melanoma	0.00084	0.00446	CcSEcCtD
Etravirine—Erythema multiforme—Dactinomycin—melanoma	0.000834	0.00443	CcSEcCtD
Etravirine—Hypoaesthesia—Carmustine—melanoma	0.000821	0.00436	CcSEcCtD
Etravirine—Hypersensitivity—Vemurafenib—melanoma	0.000817	0.00434	CcSEcCtD
Etravirine—Connective tissue disorder—Carmustine—melanoma	0.000811	0.00431	CcSEcCtD
Etravirine—Atrial fibrillation—Docetaxel—melanoma	0.000809	0.0043	CcSEcCtD
Etravirine—Dermatitis bullous—Docetaxel—melanoma	0.000802	0.00426	CcSEcCtD
Etravirine—Hepatitis—Temozolomide—melanoma	0.000798	0.00424	CcSEcCtD
Etravirine—Asthenia—Vemurafenib—melanoma	0.000796	0.00422	CcSEcCtD
Etravirine—Hypoaesthesia—Temozolomide—melanoma	0.000794	0.00421	CcSEcCtD
Etravirine—Urinary tract disorder—Temozolomide—melanoma	0.000788	0.00418	CcSEcCtD
Etravirine—Connective tissue disorder—Temozolomide—melanoma	0.000784	0.00416	CcSEcCtD
Etravirine—Urethral disorder—Temozolomide—melanoma	0.000782	0.00415	CcSEcCtD
Etravirine—Eye disorder—Carmustine—melanoma	0.000771	0.0041	CcSEcCtD
Etravirine—Ill-defined disorder—Bleomycin—melanoma	0.000764	0.00406	CcSEcCtD
Etravirine—Anaemia—Bleomycin—melanoma	0.000761	0.00404	CcSEcCtD
Etravirine—Diarrhoea—Vemurafenib—melanoma	0.000759	0.00403	CcSEcCtD
Etravirine—Erythema multiforme—Temozolomide—melanoma	0.000754	0.004	CcSEcCtD
Etravirine—Eye disorder—Temozolomide—melanoma	0.000745	0.00396	CcSEcCtD
Etravirine—Malaise—Bleomycin—melanoma	0.000742	0.00394	CcSEcCtD
Etravirine—Cardiac disorder—Temozolomide—melanoma	0.00074	0.00393	CcSEcCtD
Etravirine—Dizziness—Vemurafenib—melanoma	0.000733	0.00389	CcSEcCtD
Etravirine—Angiopathy—Temozolomide—melanoma	0.000724	0.00384	CcSEcCtD
Etravirine—Mental disorder—Carmustine—melanoma	0.000723	0.00384	CcSEcCtD
Etravirine—Immune system disorder—Temozolomide—melanoma	0.00072	0.00383	CcSEcCtD
Etravirine—Mediastinal disorder—Temozolomide—melanoma	0.000719	0.00382	CcSEcCtD
Etravirine—Malnutrition—Carmustine—melanoma	0.000719	0.00382	CcSEcCtD
Etravirine—Ill-defined disorder—Dactinomycin—melanoma	0.000712	0.00378	CcSEcCtD
Etravirine—Anaemia—Dactinomycin—melanoma	0.00071	0.00377	CcSEcCtD
Etravirine—Vomiting—Vemurafenib—melanoma	0.000705	0.00374	CcSEcCtD
Etravirine—Dry skin—Docetaxel—melanoma	0.000703	0.00373	CcSEcCtD
Etravirine—Rash—Vemurafenib—melanoma	0.000699	0.00371	CcSEcCtD
Etravirine—Mental disorder—Temozolomide—melanoma	0.000699	0.00371	CcSEcCtD
Etravirine—Dermatitis—Vemurafenib—melanoma	0.000699	0.00371	CcSEcCtD
Etravirine—Headache—Vemurafenib—melanoma	0.000695	0.00369	CcSEcCtD
Etravirine—Malnutrition—Temozolomide—melanoma	0.000694	0.00369	CcSEcCtD
Etravirine—Breast disorder—Docetaxel—melanoma	0.000693	0.00368	CcSEcCtD
Etravirine—Discomfort—Bleomycin—melanoma	0.000692	0.00368	CcSEcCtD
Etravirine—Malaise—Dactinomycin—melanoma	0.000692	0.00368	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00069	0.00367	CcSEcCtD
Etravirine—Confusional state—Bleomycin—melanoma	0.000677	0.0036	CcSEcCtD
Etravirine—Vision blurred—Carmustine—melanoma	0.000677	0.0036	CcSEcCtD
Etravirine—Tremor—Carmustine—melanoma	0.000673	0.00357	CcSEcCtD
Etravirine—Infection—Bleomycin—melanoma	0.000667	0.00354	CcSEcCtD
Etravirine—Anaemia—Carmustine—melanoma	0.000664	0.00353	CcSEcCtD
Etravirine—Nausea—Vemurafenib—melanoma	0.000659	0.0035	CcSEcCtD
Etravirine—Thrombocytopenia—Bleomycin—melanoma	0.000658	0.00349	CcSEcCtD
Etravirine—Vision blurred—Temozolomide—melanoma	0.000654	0.00347	CcSEcCtD
Etravirine—Bronchospasm—Docetaxel—melanoma	0.000652	0.00346	CcSEcCtD
Etravirine—Tremor—Temozolomide—melanoma	0.000651	0.00345	CcSEcCtD
Etravirine—Discomfort—Dactinomycin—melanoma	0.000646	0.00343	CcSEcCtD
Etravirine—Angina pectoris—Docetaxel—melanoma	0.000646	0.00343	CcSEcCtD
Etravirine—Ill-defined disorder—Temozolomide—melanoma	0.000644	0.00342	CcSEcCtD
Etravirine—Anaemia—Temozolomide—melanoma	0.000642	0.00341	CcSEcCtD
Etravirine—Anorexia—Bleomycin—melanoma	0.00064	0.0034	CcSEcCtD
Etravirine—Angioedema—Temozolomide—melanoma	0.000634	0.00337	CcSEcCtD
Etravirine—Malaise—Temozolomide—melanoma	0.000626	0.00332	CcSEcCtD
Etravirine—Vertigo—Temozolomide—melanoma	0.000624	0.00331	CcSEcCtD
Etravirine—Convulsion—Carmustine—melanoma	0.000623	0.00331	CcSEcCtD
Etravirine—Infection—Dactinomycin—melanoma	0.000622	0.00331	CcSEcCtD
Etravirine—Hypertension—Carmustine—melanoma	0.00062	0.00329	CcSEcCtD
Etravirine—Thrombocytopenia—Dactinomycin—melanoma	0.000613	0.00326	CcSEcCtD
Etravirine—Anxiety—Carmustine—melanoma	0.00061	0.00324	CcSEcCtD
Etravirine—Paraesthesia—Bleomycin—melanoma	0.000603	0.0032	CcSEcCtD
Etravirine—Convulsion—Temozolomide—melanoma	0.000602	0.00319	CcSEcCtD
Etravirine—Hypertension—Temozolomide—melanoma	0.0006	0.00318	CcSEcCtD
Etravirine—Anorexia—Dactinomycin—melanoma	0.000597	0.00317	CcSEcCtD
Etravirine—Confusional state—Carmustine—melanoma	0.000591	0.00314	CcSEcCtD
Etravirine—Anxiety—Temozolomide—melanoma	0.000589	0.00313	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000587	0.00312	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000586	0.00311	CcSEcCtD
Etravirine—Discomfort—Temozolomide—melanoma	0.000584	0.0031	CcSEcCtD
Etravirine—Decreased appetite—Bleomycin—melanoma	0.000584	0.0031	CcSEcCtD
Etravirine—Infection—Carmustine—melanoma	0.000583	0.00309	CcSEcCtD
Etravirine—Acute coronary syndrome—Docetaxel—melanoma	0.000583	0.00309	CcSEcCtD
Etravirine—Renal failure—Docetaxel—melanoma	0.000581	0.00308	CcSEcCtD
Etravirine—Myocardial infarction—Docetaxel—melanoma	0.000579	0.00308	CcSEcCtD
Etravirine—Neuropathy peripheral—Docetaxel—melanoma	0.000579	0.00308	CcSEcCtD
Etravirine—Dry mouth—Temozolomide—melanoma	0.000578	0.00307	CcSEcCtD
Etravirine—Stomatitis—Docetaxel—melanoma	0.000576	0.00306	CcSEcCtD
Etravirine—Pain—Bleomycin—melanoma	0.000575	0.00305	CcSEcCtD
Etravirine—Conjunctivitis—Docetaxel—melanoma	0.000574	0.00305	CcSEcCtD
Etravirine—Thrombocytopenia—Carmustine—melanoma	0.000574	0.00305	CcSEcCtD
Etravirine—Confusional state—Temozolomide—melanoma	0.000571	0.00303	CcSEcCtD
Etravirine—Infection—Temozolomide—melanoma	0.000563	0.00299	CcSEcCtD
Etravirine—Anorexia—Carmustine—melanoma	0.000559	0.00297	CcSEcCtD
Etravirine—Hepatobiliary disease—Docetaxel—melanoma	0.000559	0.00297	CcSEcCtD
Etravirine—Nervous system disorder—Temozolomide—melanoma	0.000556	0.00295	CcSEcCtD
Etravirine—Thrombocytopenia—Temozolomide—melanoma	0.000555	0.00295	CcSEcCtD
Etravirine—Feeling abnormal—Bleomycin—melanoma	0.000554	0.00294	CcSEcCtD
Etravirine—Skin disorder—Temozolomide—melanoma	0.00055	0.00292	CcSEcCtD
Etravirine—Hyperhidrosis—Temozolomide—melanoma	0.000548	0.00291	CcSEcCtD
Etravirine—Decreased appetite—Dactinomycin—melanoma	0.000545	0.00289	CcSEcCtD
Etravirine—Fatigue—Dactinomycin—melanoma	0.00054	0.00287	CcSEcCtD
Etravirine—Anorexia—Temozolomide—melanoma	0.00054	0.00287	CcSEcCtD
Etravirine—Pain—Dactinomycin—melanoma	0.000536	0.00284	CcSEcCtD
Etravirine—Body temperature increased—Bleomycin—melanoma	0.000531	0.00282	CcSEcCtD
Etravirine—Hepatitis—Docetaxel—melanoma	0.00053	0.00282	CcSEcCtD
Etravirine—Insomnia—Carmustine—melanoma	0.00053	0.00282	CcSEcCtD
Etravirine—Hypoaesthesia—Docetaxel—melanoma	0.000528	0.0028	CcSEcCtD
Etravirine—Paraesthesia—Carmustine—melanoma	0.000527	0.0028	CcSEcCtD
Etravirine—Urinary tract disorder—Docetaxel—melanoma	0.000524	0.00278	CcSEcCtD
Etravirine—Somnolence—Carmustine—melanoma	0.000521	0.00277	CcSEcCtD
Etravirine—Connective tissue disorder—Docetaxel—melanoma	0.000521	0.00277	CcSEcCtD
Etravirine—Urethral disorder—Docetaxel—melanoma	0.00052	0.00276	CcSEcCtD
Etravirine—Feeling abnormal—Dactinomycin—melanoma	0.000516	0.00274	CcSEcCtD
Etravirine—Insomnia—Temozolomide—melanoma	0.000513	0.00272	CcSEcCtD
Etravirine—Gastrointestinal pain—Dactinomycin—melanoma	0.000512	0.00272	CcSEcCtD
Etravirine—Decreased appetite—Carmustine—melanoma	0.00051	0.00271	CcSEcCtD
Etravirine—Paraesthesia—Temozolomide—melanoma	0.000509	0.0027	CcSEcCtD
Etravirine—Gastrointestinal disorder—Carmustine—melanoma	0.000506	0.00269	CcSEcCtD
Etravirine—Somnolence—Temozolomide—melanoma	0.000504	0.00267	CcSEcCtD
Etravirine—Erythema multiforme—Docetaxel—melanoma	0.000502	0.00266	CcSEcCtD
Etravirine—Pain—Carmustine—melanoma	0.000501	0.00266	CcSEcCtD
Etravirine—Constipation—Carmustine—melanoma	0.000501	0.00266	CcSEcCtD
Etravirine—Eye disorder—Docetaxel—melanoma	0.000496	0.00263	CcSEcCtD
Etravirine—Body temperature increased—Dactinomycin—melanoma	0.000495	0.00263	CcSEcCtD
Etravirine—Abdominal pain—Dactinomycin—melanoma	0.000495	0.00263	CcSEcCtD
Etravirine—Hypersensitivity—Bleomycin—melanoma	0.000495	0.00263	CcSEcCtD
Etravirine—Decreased appetite—Temozolomide—melanoma	0.000493	0.00262	CcSEcCtD
Etravirine—Cardiac disorder—Docetaxel—melanoma	0.000492	0.00261	CcSEcCtD
Etravirine—Gastrointestinal disorder—Temozolomide—melanoma	0.000489	0.0026	CcSEcCtD
Etravirine—Fatigue—Temozolomide—melanoma	0.000489	0.00259	CcSEcCtD
Etravirine—Constipation—Temozolomide—melanoma	0.000485	0.00257	CcSEcCtD
Etravirine—Pain—Temozolomide—melanoma	0.000485	0.00257	CcSEcCtD
Etravirine—Feeling abnormal—Carmustine—melanoma	0.000483	0.00257	CcSEcCtD
Etravirine—Asthenia—Bleomycin—melanoma	0.000482	0.00256	CcSEcCtD
Etravirine—Angiopathy—Docetaxel—melanoma	0.000481	0.00256	CcSEcCtD
Etravirine—Gastrointestinal pain—Carmustine—melanoma	0.00048	0.00255	CcSEcCtD
Etravirine—Immune system disorder—Docetaxel—melanoma	0.000479	0.00254	CcSEcCtD
Etravirine—Mediastinal disorder—Docetaxel—melanoma	0.000478	0.00254	CcSEcCtD
Etravirine—Feeling abnormal—Temozolomide—melanoma	0.000467	0.00248	CcSEcCtD
Etravirine—Mental disorder—Docetaxel—melanoma	0.000465	0.00247	CcSEcCtD
Etravirine—Abdominal pain—Carmustine—melanoma	0.000464	0.00246	CcSEcCtD
Etravirine—Body temperature increased—Carmustine—melanoma	0.000464	0.00246	CcSEcCtD
Etravirine—Gastrointestinal pain—Temozolomide—melanoma	0.000463	0.00246	CcSEcCtD
Etravirine—Malnutrition—Docetaxel—melanoma	0.000462	0.00245	CcSEcCtD
Etravirine—Hypersensitivity—Dactinomycin—melanoma	0.000462	0.00245	CcSEcCtD
Etravirine—Asthenia—Dactinomycin—melanoma	0.00045	0.00239	CcSEcCtD
Etravirine—Body temperature increased—Temozolomide—melanoma	0.000448	0.00238	CcSEcCtD
Etravirine—Abdominal pain—Temozolomide—melanoma	0.000448	0.00238	CcSEcCtD
Etravirine—Hypersensitivity—Carmustine—melanoma	0.000432	0.00229	CcSEcCtD
Etravirine—Diarrhoea—Dactinomycin—melanoma	0.000429	0.00228	CcSEcCtD
Etravirine—Vomiting—Bleomycin—melanoma	0.000427	0.00227	CcSEcCtD
Etravirine—Anaemia—Docetaxel—melanoma	0.000427	0.00227	CcSEcCtD
Etravirine—Rash—Bleomycin—melanoma	0.000424	0.00225	CcSEcCtD
Etravirine—Dermatitis—Bleomycin—melanoma	0.000423	0.00225	CcSEcCtD
Etravirine—Asthenia—Carmustine—melanoma	0.000421	0.00223	CcSEcCtD
Etravirine—Hypersensitivity—Temozolomide—melanoma	0.000418	0.00222	CcSEcCtD
Etravirine—Syncope—Docetaxel—melanoma	0.000414	0.0022	CcSEcCtD
Etravirine—Asthenia—Temozolomide—melanoma	0.000407	0.00216	CcSEcCtD
Etravirine—Loss of consciousness—Docetaxel—melanoma	0.000406	0.00215	CcSEcCtD
Etravirine—Diarrhoea—Carmustine—melanoma	0.000401	0.00213	CcSEcCtD
Etravirine—Convulsion—Docetaxel—melanoma	0.0004	0.00212	CcSEcCtD
Etravirine—Nausea—Bleomycin—melanoma	0.000399	0.00212	CcSEcCtD
Etravirine—Hypertension—Docetaxel—melanoma	0.000399	0.00212	CcSEcCtD
Etravirine—Vomiting—Dactinomycin—melanoma	0.000398	0.00212	CcSEcCtD
Etravirine—Rash—Dactinomycin—melanoma	0.000395	0.0021	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00039	0.00207	CcSEcCtD
Etravirine—Dizziness—Carmustine—melanoma	0.000388	0.00206	CcSEcCtD
Etravirine—Diarrhoea—Temozolomide—melanoma	0.000388	0.00206	CcSEcCtD
Etravirine—Dry mouth—Docetaxel—melanoma	0.000384	0.00204	CcSEcCtD
Etravirine—Confusional state—Docetaxel—melanoma	0.00038	0.00202	CcSEcCtD
Etravirine—Dizziness—Temozolomide—melanoma	0.000375	0.00199	CcSEcCtD
Etravirine—Infection—Docetaxel—melanoma	0.000374	0.00199	CcSEcCtD
Etravirine—Vomiting—Carmustine—melanoma	0.000373	0.00198	CcSEcCtD
Etravirine—Nausea—Dactinomycin—melanoma	0.000372	0.00198	CcSEcCtD
Etravirine—Shock—Docetaxel—melanoma	0.000371	0.00197	CcSEcCtD
Etravirine—Rash—Carmustine—melanoma	0.00037	0.00196	CcSEcCtD
Etravirine—Nervous system disorder—Docetaxel—melanoma	0.00037	0.00196	CcSEcCtD
Etravirine—Dermatitis—Carmustine—melanoma	0.000369	0.00196	CcSEcCtD
Etravirine—Thrombocytopenia—Docetaxel—melanoma	0.000369	0.00196	CcSEcCtD
Etravirine—Headache—Carmustine—melanoma	0.000367	0.00195	CcSEcCtD
Etravirine—Skin disorder—Docetaxel—melanoma	0.000366	0.00194	CcSEcCtD
Etravirine—Vomiting—Temozolomide—melanoma	0.00036	0.00191	CcSEcCtD
Etravirine—Anorexia—Docetaxel—melanoma	0.000359	0.00191	CcSEcCtD
Etravirine—Rash—Temozolomide—melanoma	0.000357	0.0019	CcSEcCtD
Etravirine—Dermatitis—Temozolomide—melanoma	0.000357	0.0019	CcSEcCtD
Etravirine—Headache—Temozolomide—melanoma	0.000355	0.00189	CcSEcCtD
Etravirine—Nausea—Carmustine—melanoma	0.000348	0.00185	CcSEcCtD
Etravirine—Insomnia—Docetaxel—melanoma	0.000341	0.00181	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—melanoma	0.000338	0.0018	CcSEcCtD
Etravirine—Nausea—Temozolomide—melanoma	0.000337	0.00179	CcSEcCtD
Etravirine—Somnolence—Docetaxel—melanoma	0.000335	0.00178	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—melanoma	0.000328	0.00174	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—melanoma	0.000325	0.00173	CcSEcCtD
Etravirine—Fatigue—Docetaxel—melanoma	0.000325	0.00173	CcSEcCtD
Etravirine—Pain—Docetaxel—melanoma	0.000322	0.00171	CcSEcCtD
Etravirine—Constipation—Docetaxel—melanoma	0.000322	0.00171	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—melanoma	0.000311	0.00165	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—melanoma	0.000308	0.00164	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—melanoma	0.000298	0.00158	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—melanoma	0.000298	0.00158	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—melanoma	0.000278	0.00147	CcSEcCtD
Etravirine—Asthenia—Docetaxel—melanoma	0.00027	0.00144	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—melanoma	0.000258	0.00137	CcSEcCtD
Etravirine—Dizziness—Docetaxel—melanoma	0.000249	0.00132	CcSEcCtD
Etravirine—Vomiting—Docetaxel—melanoma	0.00024	0.00127	CcSEcCtD
Etravirine—Rash—Docetaxel—melanoma	0.000238	0.00126	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—melanoma	0.000237	0.00126	CcSEcCtD
Etravirine—Headache—Docetaxel—melanoma	0.000236	0.00125	CcSEcCtD
Etravirine—Nausea—Docetaxel—melanoma	0.000224	0.00119	CcSEcCtD
Etravirine—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	4.78e-05	0.00178	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ABCB1—melanoma	4.77e-05	0.00178	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CASP8—melanoma	4.49e-05	0.00168	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP1B1—melanoma	4.47e-05	0.00167	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP1B1—melanoma	4.41e-05	0.00164	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PRKCA—melanoma	4.39e-05	0.00164	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ERCC2—melanoma	4.36e-05	0.00163	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	4.3e-05	0.00161	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	4.14e-05	0.00155	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP1B1—melanoma	4.08e-05	0.00152	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	4.05e-05	0.00151	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	4.02e-05	0.0015	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	3.89e-05	0.00145	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IFNG—melanoma	3.82e-05	0.00143	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	3.76e-05	0.0014	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	3.7e-05	0.00138	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.61e-05	0.00135	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	3.61e-05	0.00135	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CXCL8—melanoma	3.55e-05	0.00133	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CG—melanoma	3.44e-05	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CASP3—melanoma	3.4e-05	0.00127	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2—melanoma	3.4e-05	0.00127	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.38e-05	0.00126	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	3.38e-05	0.00126	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	3.33e-05	0.00124	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PPARG—melanoma	3.32e-05	0.00124	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.19e-05	0.00119	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	3.17e-05	0.00118	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.16e-05	0.00118	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.15e-05	0.00117	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	3.1e-05	0.00116	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.08e-05	0.00115	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	3.07e-05	0.00115	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	3.04e-05	0.00113	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CD—melanoma	3.03e-05	0.00113	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALB—melanoma	2.99e-05	0.00111	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	2.98e-05	0.00111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACER3—melanoma	2.98e-05	0.00111	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	2.93e-05	0.00109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACER3—melanoma	2.91e-05	0.00108	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—melanoma	2.89e-05	0.00108	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.89e-05	0.00108	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	2.88e-05	0.00107	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	2.82e-05	0.00105	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—UGT2B10—melanoma	2.73e-05	0.00102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACER3—melanoma	2.72e-05	0.00101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.69e-05	0.001	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.69e-05	0.001	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	2.68e-05	0.000999	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—UGT2B10—melanoma	2.66e-05	0.000992	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.65e-05	0.000989	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CB—melanoma	2.64e-05	0.000984	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—melanoma	2.61e-05	0.000975	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	2.54e-05	0.000948	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HS3ST5—melanoma	2.53e-05	0.000945	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	2.53e-05	0.000944	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—UGT2B10—melanoma	2.48e-05	0.000927	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—melanoma	2.47e-05	0.000923	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HS3ST5—melanoma	2.47e-05	0.000923	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.45e-05	0.000915	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.38e-05	0.000888	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.35e-05	0.000878	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HS3ST5—melanoma	2.31e-05	0.000862	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTEN—melanoma	2.28e-05	0.00085	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.22e-05	0.000827	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.18e-05	0.000813	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.13e-05	0.000793	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.11e-05	0.000786	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.04e-05	0.000761	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2e-05	0.000748	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLCB4—melanoma	1.92e-05	0.000716	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.9e-05	0.00071	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	1.88e-05	0.000703	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.88e-05	0.0007	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLCB4—melanoma	1.87e-05	0.000699	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.86e-05	0.000694	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.85e-05	0.00069	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.81e-05	0.000675	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIP4K2A—melanoma	1.81e-05	0.000673	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC6A11—melanoma	1.81e-05	0.000673	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACER3—melanoma	1.79e-05	0.000668	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIP4K2A—melanoma	1.76e-05	0.000657	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC6A11—melanoma	1.76e-05	0.000657	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTAP—melanoma	1.76e-05	0.000655	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCB4—melanoma	1.75e-05	0.000653	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.72e-05	0.000642	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.72e-05	0.000641	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.72e-05	0.00064	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTAP—melanoma	1.71e-05	0.000639	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.71e-05	0.000639	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.68e-05	0.000626	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIP4K2A—melanoma	1.65e-05	0.000614	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC6A11—melanoma	1.65e-05	0.000614	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UGT2B10—melanoma	1.64e-05	0.000611	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.63e-05	0.000609	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.62e-05	0.000604	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—melanoma	1.61e-05	0.0006	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTAP—melanoma	1.6e-05	0.000597	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.58e-05	0.00059	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.58e-05	0.000588	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.57e-05	0.000585	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LUM—melanoma	1.57e-05	0.000584	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PHGDH—melanoma	1.57e-05	0.000584	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.56e-05	0.000584	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HPSE—melanoma	1.53e-05	0.000573	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PHGDH—melanoma	1.53e-05	0.00057	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LUM—melanoma	1.53e-05	0.00057	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HS3ST5—melanoma	1.52e-05	0.000568	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CUBN—melanoma	1.51e-05	0.000562	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HPSE—melanoma	1.5e-05	0.000559	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CUBN—melanoma	1.47e-05	0.000549	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BSG—melanoma	1.46e-05	0.000543	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CSPG4—melanoma	1.46e-05	0.000543	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SDHD—melanoma	1.46e-05	0.000543	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PHGDH—melanoma	1.43e-05	0.000532	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LUM—melanoma	1.43e-05	0.000532	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.42e-05	0.000531	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SDHD—melanoma	1.42e-05	0.00053	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CSPG4—melanoma	1.42e-05	0.00053	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BSG—melanoma	1.42e-05	0.00053	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPAM—melanoma	1.41e-05	0.000526	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HPSE—melanoma	1.4e-05	0.000522	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPAM—melanoma	1.38e-05	0.000513	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CUBN—melanoma	1.37e-05	0.000513	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.35e-05	0.000503	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SDHD—melanoma	1.33e-05	0.000495	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CSPG4—melanoma	1.33e-05	0.000495	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BSG—melanoma	1.33e-05	0.000495	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKT1—melanoma	1.31e-05	0.00049	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.31e-05	0.000489	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPAM—melanoma	1.28e-05	0.000479	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.28e-05	0.000478	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.28e-05	0.000478	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.22e-05	0.000455	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.21e-05	0.000452	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLA2G6—melanoma	1.2e-05	0.000447	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLA2G6—melanoma	1.17e-05	0.000436	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCB4—melanoma	1.15e-05	0.000431	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.11e-05	0.000415	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLA2G6—melanoma	1.09e-05	0.000408	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC6A11—melanoma	1.09e-05	0.000405	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.09e-05	0.000405	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—VCAN—melanoma	1.08e-05	0.000402	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.08e-05	0.000401	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTAP—melanoma	1.06e-05	0.000394	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—VCAN—melanoma	1.05e-05	0.000392	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.02e-05	0.00038	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.83e-06	0.000367	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—VCAN—melanoma	9.81e-06	0.000366	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LUM—melanoma	9.41e-06	0.000351	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PHGDH—melanoma	9.41e-06	0.000351	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.29e-06	0.000347	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HPSE—melanoma	9.23e-06	0.000344	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.09e-06	0.000339	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP17A1—melanoma	9.08e-06	0.000339	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CUBN—melanoma	9.06e-06	0.000338	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.97e-06	0.000335	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.96e-06	0.000334	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP17A1—melanoma	8.86e-06	0.000331	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.84e-06	0.00033	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SDHD—melanoma	8.75e-06	0.000326	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BSG—melanoma	8.75e-06	0.000326	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CSPG4—melanoma	8.75e-06	0.000326	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GNA11—melanoma	8.58e-06	0.00032	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPAM—melanoma	8.47e-06	0.000316	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FASN—melanoma	8.39e-06	0.000313	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GNA11—melanoma	8.37e-06	0.000312	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP17A1—melanoma	8.28e-06	0.000309	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC5A5—melanoma	8.26e-06	0.000308	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.21e-06	0.000306	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FASN—melanoma	8.19e-06	0.000306	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.17e-06	0.000305	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.06e-06	0.000301	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC5A5—melanoma	8.06e-06	0.000301	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CD44—melanoma	7.97e-06	0.000297	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GNAQ—melanoma	7.97e-06	0.000297	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GNA11—melanoma	7.82e-06	0.000292	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.81e-06	0.000291	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GNAQ—melanoma	7.78e-06	0.00029	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CD44—melanoma	7.78e-06	0.00029	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.74e-06	0.000289	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FASN—melanoma	7.65e-06	0.000285	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1B1—melanoma	7.64e-06	0.000285	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC5A5—melanoma	7.53e-06	0.000281	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1B1—melanoma	7.46e-06	0.000278	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GNAQ—melanoma	7.27e-06	0.000271	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CD44—melanoma	7.27e-06	0.000271	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLA2G6—melanoma	7.21e-06	0.000269	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.12e-06	0.000266	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.05e-06	0.000263	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1B1—melanoma	6.97e-06	0.00026	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.75e-06	0.000252	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—VCAN—melanoma	6.47e-06	0.000241	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—melanoma	6.29e-06	0.000235	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.15e-06	0.000229	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PRKCA—melanoma	5.79e-06	0.000216	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ERCC2—melanoma	5.75e-06	0.000214	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—melanoma	5.74e-06	0.000214	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PRKCA—melanoma	5.65e-06	0.000211	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ERCC2—melanoma	5.61e-06	0.000209	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP17A1—melanoma	5.46e-06	0.000204	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PRKCA—melanoma	5.28e-06	0.000197	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ERCC2—melanoma	5.24e-06	0.000195	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GNA11—melanoma	5.16e-06	0.000192	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FASN—melanoma	5.05e-06	0.000188	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A5—melanoma	4.96e-06	0.000185	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CD44—melanoma	4.79e-06	0.000179	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GNAQ—melanoma	4.79e-06	0.000179	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.76e-06	0.000178	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1B1—melanoma	4.6e-06	0.000171	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—melanoma	4.54e-06	0.000169	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—melanoma	4.43e-06	0.000165	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARG—melanoma	4.38e-06	0.000163	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.34e-06	0.000162	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARG—melanoma	4.27e-06	0.000159	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—melanoma	4.14e-06	0.000154	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARG—melanoma	3.99e-06	0.000149	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CD—melanoma	3.99e-06	0.000149	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—melanoma	3.94e-06	0.000147	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CD—melanoma	3.89e-06	0.000145	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—melanoma	3.84e-06	0.000143	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—melanoma	3.79e-06	0.000141	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CD—melanoma	3.64e-06	0.000136	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—melanoma	3.59e-06	0.000134	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PRKCA—melanoma	3.48e-06	0.00013	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CB—melanoma	3.48e-06	0.00013	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ERCC2—melanoma	3.45e-06	0.000129	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—melanoma	3.44e-06	0.000129	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CB—melanoma	3.39e-06	0.000127	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—melanoma	3.36e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CB—melanoma	3.17e-06	0.000118	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—melanoma	3.14e-06	0.000117	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—melanoma	3e-06	0.000112	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—melanoma	2.93e-06	0.000109	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—melanoma	2.74e-06	0.000102	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—melanoma	2.73e-06	0.000102	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARG—melanoma	2.63e-06	9.82e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CD—melanoma	2.4e-06	8.95e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—melanoma	2.37e-06	8.83e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—melanoma	2.12e-06	7.91e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CB—melanoma	2.09e-06	7.8e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—melanoma	2.07e-06	7.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—melanoma	2.07e-06	7.72e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—melanoma	1.93e-06	7.21e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—melanoma	1.81e-06	6.74e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—melanoma	1.73e-06	6.46e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—melanoma	1.69e-06	6.3e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—melanoma	1.58e-06	5.89e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—melanoma	1.27e-06	4.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—melanoma	1.04e-06	3.88e-05	CbGpPWpGaD
